A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2006
11/30/2006	US20060270660 Processes for preparing substituted pyrimidines
11/30/2006	US20060270649 Azetidine derivatives, their preparation and medicaments containing them
11/30/2006	US20060270636 Methods for treatment of neuro- and nephro- disorders and therapeutic toxicities using aminothiol compounds
11/30/2006	US20060270624 Gapped 2' modified oligonucleotides
11/30/2006	US20060270618 Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
11/30/2006	US20060270606 Dolastatin 15 derivatives
11/30/2006	US20060270599 Inhibiting angiogenesis using molecules that enhance plasmin formation or prolong plasmin activity
11/30/2006	US20060269956 Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571
11/30/2006	US20060269954 Self-assembling recombinant papillomavirus capsid proteins
11/30/2006	US20060269912 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/30/2006	US20060269627 Isolation of a Dual Cox-2 and 5-Lipoxygenase Inhibitor from Acacia
11/30/2006	US20060269625 Methods of inhibiting proliferation of cells
11/30/2006	US20060269613 Composition containing nanoparticles containing water-soluble basic drug encpsulated therein
11/30/2006	US20060269594 Liposomal antineoplastic drugs and uses thereof
11/30/2006	US20060269565 Administering a polypeptide fused to an Fc, has T-cell proliferation inhibiting activity to treat autoimmune encephalomyelitis
11/30/2006	US20060269555 Tumor necrosis factor (TNF)-related apoptosis-inducing ligands; anticarcinogenic and antiproliferative agents; graft versus host disease, AIDS, neurodegenerative disorders
11/30/2006	US20060269552 Heparanase activity neutralizing anti-heparanase monclonal antibody and other anti-heparanase antibodies
11/30/2006	US20060269548 Lymphatic endothelial cells materials and methods
11/30/2006	US20060269547 Humanized anti-CD3 specific antibodies
11/30/2006	US20060269539 Genetic engineering; Alzheimer's agents; anticancer agents
11/30/2006	US20060269524 Composition for nkt cell activation
11/30/2006	US20060269511 Multilayer binding; lamellar surface structure containing at least two binding compounds is assembled under conditions in which the binding compounds self-regulate in or on the lamellar structure; organized mobile multifunctional conjugate (OMMC) assembly
11/30/2006	DE19781703B4 Gegen Tumoren wirksame Anthracyclindisaccharide, Fermentationsverfahren zu deren Herstellung und diese enthaltende therapeutische Zusammensetzung Effective against tumors Anthracyclindisaccharide, fermentation processes for their preparation and therapeutic composition containing them
11/30/2006	DE102005024245A1 Thienopyridine Thienopyridines
11/30/2006	CA2610647A1 Novel inhibitors of pyruvate kinase as therapeutic agents for cancer
11/30/2006	CA2610357A1 Antibody or antibody fragment coupled with an immunogenic agent
11/30/2006	CA2609511A1 Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate
11/30/2006	CA2609391A1 Quinazolinones
11/30/2006	CA2609389A1 Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
11/30/2006	CA2609387A1 Combination therapy comprising diaryl ureas for treating diseases
11/30/2006	CA2609385A1 Thienopyridines
11/30/2006	CA2609202A1 Apoptosis promoters
11/30/2006	CA2609186A1 Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
11/30/2006	CA2609126A1 Pyrrolopyridines useful as inhibitors of protein kinase
11/30/2006	CA2609004A1 Tetrahydropyridothiophenes for use in the treatment of cancer
11/30/2006	CA2609003A1 Tetrahydropyridothiophenes for use in the treatment of cancer
11/30/2006	CA2545557A1 Stromal antigen-presenting cells and use thereof
11/29/2006	EP1726310A1 Medicine for cancer therapy
11/29/2006	EP1725657A1 Prostatic acid phosphatase antigens
11/29/2006	EP1725565A2 Fused heterotricyclic compounds as inhibitors of 17b-hydroxysteroid dehydrogenase 3
11/29/2006	EP1725553A1 Tetrahydropyridoindole derivatives
11/29/2006	EP1725551A1 Oxidized thioether derivatives of styryl-azoles and their use as her tyrosine kinases inhibitors
11/29/2006	EP1725550A2 Pyrrole-derivatives as factor xa inhibitors
11/29/2006	EP1725549A1 Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
11/29/2006	EP1725538A1 Pyridazinone ureas as antagonists of a4 integrins
11/29/2006	EP1725531A2 Inhibitors of dna methylation in tumor cells
11/29/2006	EP1725261A2 Use for interleukin-33 (il-33) and the il-33 receptor complex
11/29/2006	EP1725252A2 Antitumour treatments with metxia-p450 and cyclophosphamide or 5t4 vaccine
11/29/2006	EP1725247A1 Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation
11/29/2006	EP1725233A1 Sns-595 and methods of using the same
11/29/2006	EP1497656B1 Diagnosis of carcinoma using raig1 polypeptides
11/29/2006	EP1478381A4 Use of soluble gamma delta t cell receptors for regulating t cell function
11/29/2006	EP1401474B1 Methods for inducing sustained immune response
11/29/2006	EP1313504B1 Methods and compositions for inhibiting angiogenesis
11/29/2006	EP1299039B1 Surgical high pressure liquid jet device with liquid medicament
11/29/2006	EP1259223A4 Protein matrix materials, devices and methods of making and using thereof
11/29/2006	EP1239886B1 Labelled ascorbic acid derivatives
11/29/2006	EP1220911B1 P-glycoproteins and uses thereof
11/29/2006	EP1206529B1 UDP-N-ACETYLGLUCOSAMINE: GALACTOSE-BETA 1,3-N-ACETYLGALACTOSAMINE-ALPHA-R/(GlcNAc to GalNAc) BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE, C2GnT3
11/29/2006	EP1198251B1 Combination of an anti-ep-cam antibody with a chemotherapeutic agent
11/29/2006	EP1196598B1 Dsp-3 dual-specificity phosphatase
11/29/2006	EP1189936B1 Use of eif4e binding agents in therapy
11/29/2006	EP1158993B1 Bacterial membrane fractions with adjuvant effect
11/29/2006	EP1107707B1 Stent coating
11/29/2006	EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide
11/29/2006	EP0973541B1 Use of histons for the production of medicaments
11/29/2006	EP0918848B1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/29/2006	EP0789568B1 Antineoplastic cocoa extracts, methods for making, using
11/29/2006	CN1871240A Pyrrolopyrimidine thion derivatives
11/29/2006	CN1871239A Modulation of beta-catenin/tcf-activated transcription
11/29/2006	CN1871234A 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible no-synthase
11/29/2006	CN1871227A Antitumoral agent
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1871217A Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
11/29/2006	CN1871025A Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (BORIS)
11/29/2006	CN1871009A 5-arylpyrimidines as anticancer agents
11/29/2006	CN1870995A Cancer treatment with epothilones
11/29/2006	CN1869242A Recombination adenovirus and its application
11/29/2006	CN1869230A Nucleotid sequence of human interleukin 21 and method and application of producing matured human interleukin 21
11/29/2006	CN1869219A Sensibility of HSD11 gene capable of increasing sensibility of tumour cell to multipile withor induction factor
11/29/2006	CN1869207A Rat antihuman macrephage migration inhibiting factor monoclone antibody and its application
11/29/2006	CN1869206A Preparation of high efficiency immune active cell and method of using for anti tumour
11/29/2006	CN1869070A High efficiency low poison immune toxin and its preparation method and application
11/29/2006	CN1869066A Tumour antigen protein and tumour antigen peptide
11/29/2006	CN1869065A Human testis specific expression protein SPAG8 for taking part in regulating and controlling sperm generation
11/29/2006	CN1869064A Tumour antigen protein and tumour antigen peptide
11/29/2006	CN1869063A Preparation method of polypeptide for inhibiting gelatin enzyme A activity and its application
11/29/2006	CN1869062A Polypeptide for inhibiting gelatin enzyme A activity and its preparation method and application
11/29/2006	CN1869042A Antisensedigonucleotide structure with withor inhibiting factor survivin gene as target and its use
11/29/2006	CN1869035A Lactone monomer compound and its application in preparing medicine for treating cancer
11/29/2006	CN1869031A Lactone monomer compound and its application in preparing anticancer medicine
11/29/2006	CN1869026A Substituted phenyloxy acetamide/propanmide midin derivatire with anticancer activity and its preparation method
11/29/2006	CN1868999A Preparation method of 3-fluoro-5-nitro trifluor toluene
11/29/2006	CN1868545A Improved vaccines
11/29/2006	CN1868538A Composition contg. scorpion protein and SOD used as food and medicine
11/29/2006	CN1868536A Use of cell cycle regulation protein Cyclin B1 for preparing medicine for anti-human esophagus cancer invasion and transference
11/29/2006	CN1868485A Medicine composition and its application
11/29/2006	CN1868481A Traditional Chinese medicine cucurbitacine soft capsule and its prepn. method
11/29/2006	CN1868471A Methyl cantharis amine injection and its prepn. method
11/29/2006	CN1868468A Application of Maoeryisu for pharmacy

1 ... 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 ... 2211